These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18055171)

  • 1. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of systemic anticoagulation in patients undergoing vascular access surgery.
    Bhomi KK; Shrestha S; Bhattachan CL
    Nepal Med Coll J; 2008 Dec; 10(4):222-4. PubMed ID: 19558057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities.
    Salimi J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.
    Slayden GC; Spergel L; Jennings WC
    Semin Dial; 2008; 21(5):474-82. PubMed ID: 18627564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Heparin Use during Upper Extremity Arteriovenous Access Creation Does Not Affect Outcomes.
    Raulli SJ; Cheng TW; Farber A; Eslami MH; Kalish JA; Jones DW; Rybin DV; Nuhn M; Gautam A; Siracuse JJ
    Ann Vasc Surg; 2019 Feb; 55():216-221. PubMed ID: 30217706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: a single-center study.
    Yu Q; Yu H; Chen S; Wang L; Yuan W
    J Nephrol; 2011; 24(5):597-603. PubMed ID: 21240872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric patients undergoing arteriovenous fistula surgery without intraoperative heparin.
    Regus S; Almási-Sperling V; Lang W
    J Vasc Access; 2016 Nov; 17(6):494-498. PubMed ID: 27646929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of lower extremity arteriovenous grafts in patients with end-stage renal disease.
    Vogel KM; Martino MA; O'Brien SP; Kerstein MD
    South Med J; 2000 Jun; 93(6):593-5. PubMed ID: 10881776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of seroma after arteriovenous graft placement.
    Dauria DM; Dyk P; Garvin P
    J Am Coll Surg; 2006 Oct; 203(4):506-11. PubMed ID: 17000394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of systemic intraoperative anticoagulation during arteriovenous access formation for dialysis.
    Smith GE; Souroullos P; Cayton T; Harwood A; Carradice D; Chetter IC
    J Vasc Access; 2016; 17(1):1-5. PubMed ID: 26660043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of hemodialysis access in HIV-positive patients.
    Gorski TF; Gorski YC; Muney J
    Am Surg; 2002 Dec; 68(12):1104-6. PubMed ID: 12516818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
    Mathis AS; Davé N; Shah NK; Friedman GS
    Ann Pharmacother; 2004 Apr; 38(4):537-43. PubMed ID: 14766999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of early dialysis vascular-access failure after thrombolysis.
    Crikis S; Lee D; Brooks M; Power DA; Ierino FL; Levidiotis V
    Am J Nephrol; 2008; 28(2):181-9. PubMed ID: 17960056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula.
    Lee T; Barker J; Allon M
    J Am Soc Nephrol; 2007 Jun; 18(6):1936-41. PubMed ID: 17475812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of early vascular-access failure in patients on hemodialysis.
    Bahadi A; Hamzi MA; Farouki MR; Montasser D; Zajjari Y; Arache W; Hassani K; El Amrani M; Alayoud A; Hassani M; Benyahia M; Elallam M; Elkabbaj D; Oualim Z
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):83-7. PubMed ID: 22237224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arteriovenous fistula construction using femoral vein in the thigh and upper extremity: single-center experience.
    Rueda CA; Nehler MR; Kimball TA; Dimond KR; Whitehill TA; Peyton BD
    Ann Vasc Surg; 2008 Nov; 22(6):806-14. PubMed ID: 18809277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective clinical evaluation of the effects of intraoperative systemic anticoagulation in patients undergoing arteriovenous fistula surgery.
    Wang BR; Rowe VL; Ham SW; Han S; Patel K; Weaver FA; Woo K
    Am Surg; 2010 Oct; 76(10):1112-4. PubMed ID: 21105622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.